Back to Search
Start Over
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group
- Source :
- Nature Communications, Vol 15, Iss 1, Pp 1-1 (2024)
- Publication Year :
- 2024
- Publisher :
- Nature Portfolio, 2024.
- Subjects :
- Science
Subjects
Details
- Language :
- English
- ISSN :
- 20411723
- Volume :
- 15
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Nature Communications
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.7f906a81208468d94569f0e02656fa2
- Document Type :
- article
- Full Text :
- https://doi.org/10.1038/s41467-024-48915-9